Role of connexin 26 (GJB2) & mitochondrial small ribosomal RNA (mt 12S rRNA) genes in sporadic & aminoglycoside-induced non syndromic hearing impairment

Indian Journal of Medical Research

Volumn 130, Issue 4, 2009, Pages 369-378

  Lingala, Hema Bindu ^a   Sankarathi, ^b   Penagaluru, Pardhanandana Reddy ^a  

^a OSMANIA UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

Aminoglycosides; Connexins; Heterozygosity; Homoplasmic; Matrilineal

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CONNEXIN 26; GENTAMICIN; KANAMYCIN; MITOCHONDRIAL DNA; NEOMYCIN; RNA 12S; STREPTOMYCIN; TOBRAMYCIN;

AUDITORY SYSTEM FUNCTION; COCHLEA INJURY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHNIC DIFFERENCE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GRAM NEGATIVE INFECTION; HEARING IMPAIRMENT; HETEROZYGOSITY; HUMAN; KIDNEY DYSFUNCTION; MITOCHONDRIAL GENETICS; MITOCHONDRIAL GENOME; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REVIEW; VESTIBULAR DISORDER;

AMINOGLYCOSIDES; CONNEXINS; DEAFNESS; HEARING; HEARING LOSS; HUMANS; MITOCHONDRIA; MUTATION; RNA, RIBOSOMAL;

EID: 71449085238     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Rabionet R, Zelante L, Lopez-Bigas N, Agruma LD, Melchionda S, Restagno G, et al. Molecular basis of childhood deafness resulting from mutations in the GJB2 (Connexin 26) gene. Hum Genet 2000; 106: 40-4.
2. Vishnuvardhan M, Hemabindu L, Pardhanandana Reddy P, Usharani P. Perinatal risk factors for congenital sensorineural hearing loss. Ind J Otol 2006; 12: 7-12.
3. Kalatzis V, Petit C. The fundamental and medical impacts of recent progress in research on hereditary hearing loss. Hum Mol Genet 1998; 7: 1589-97.
4. Bussoli TJ, Steel KP. The molecular genetics of inherited deafness - current and future applications. J Laryngol Otol 1998; 112: 523-30.
5. Jacobs HT, Hutchin TP, Kappi T, Gillies G, Minkkinen K, Walker J, et al. Mitochondrial DNA mutations in patients with postlingual, non-syndromic hearing impairment. Eur J Hum Genet 2005; 13: 26-33.
6. Van Camp G, Smith RJH. Hereditary hearing loss. Available from: http://webh01.ua.ac.be/hhh.
7. Petit C, Levilliers J, Hardelin JP. Molecular genetics of hearing loss. Annu Rev Genet 2001; 35: 589-646.
8. Kikuchi T, Adams JC, Miyabe Y, So E, Kobayashi T. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary non syndromic deafness. Med Electron Microsc 2000; 33: 51-6.
9. Willems PJ. Genetic causes of hearing loss. N Engl J Med 2000; 342: 1101-9.
10. Guilford P, Arab SB, Blanchard S, Levilliers J, Weissenbach J, Belkahia A, et al. A non-syndromic form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nat Genet 1994; 6: 24-8.
11. Scott DA, Carmi R, Elbedour K, Duyk GM, Stone EM, Sheffield VC. Non syndromic autosomal recessive deafness is linked to the DFNB1 locus in a large inbred Bedouin family from Israel. Am J Hum Genet 1995; 57: 965-8.
12. Maw MA, Allen-Powell DR, Goodey RJ, Stewart IA, Nancarrow DJ, Hayward NK, et al. The contribution of the DFNB1 locus to neurosensory deafness in a Caucasian population. Am J Hum Genet 1995; 57: 629-35.
13. Brown KA, Janjua AH, Karbani G, Parry G, Noble A, Crockford G, et al. Linkage studies of non-syndromic recessive deafness (NSRD) in a family originating from the Mirpur region of Pakistan maps DFNB1 centromeric to D13S175. Hum Mol Genet 1996; 5: 169-73.
14. Thonnisen E, Rabionet R, Arbones ML, Estivill X, Willecke K, Olt T. Human connexin 26 (GJB2) deafness mutations affect the function of gap junction channels at different levels of protein expression. Hum Genet 2002; 111: 190-7.
15. Berthoud VM, Minogue PJ, Guo J, Williamson EK, Xu X, Ebihara L, et al. Loss of function and impaired degradation of a cataract-associated mutant connexin 50. Eur J Cell Biol 2003; 82: 209-21.
16. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 1996; 238: 1-27.
17. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84: 381-8.
18. Choung YH, Moon SK, Park HJ. Functional study of GJB2 in hereditary hearing loss. Laryngoscope 2002; 112: 1667-71.
19. Krutovskikh V, Yamasaki H. Connexin gene mutations in human genetic diseases. Mutat Res 2000; 462: 197-207.
20. Alvarez A, del Castillo I, Villamar M, Aguirre LA, Gonzalez-Neira A, Lopez-Nevot A, et al. High prevalence of the W24X mutation in the gene encoding Connexin-26 (GJB2) in Spanish Romani (Gypsies) with autosomal recessive non-syndromic hearing loss. Am J Med Genet 2005; 137: 255-8.
21. Jobling MA, Hurles M, Tyler-Smith C, editors. What happens when populations meet? In: Human evolutionary genetics: Origins, peoples & disease. New York: Garland Science Publishing, 2004. p. 390-2.
22. Rickard S, Kelsell DP, Sirimana T, Rajput K, MacArdle B, Bitner-Glindzicz M. Recurrent mutations in the deafness gene GJB2 (connexin 26) in British Asian families. J Med Genet 2001; 38: 530-3.
23. Sugata A, Fukushima K, Sugata K, Fukuda S, Kimura N, Gunduz M, et al. High-throughput screening for GJB2 mutations- its clinical application to genetic testing in prelingual deafness screening for GJB2 mutations. Auris Nasus Larynx 2002; 29: 231-9.
24. Ohtsuka A, Yuge I, Kimura S, Namba A, Abe S, Van Laer L, et al. GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation. Hum Genet 2003; 112: 329-33.
25. Liu XZ, Xia XJ, Ke XM, Ouyang XM, Du LL, Liu YH, et al. The prevalence of connexion 26 (GJB2) mutations in the Chinese population. Hum Genet 2002; 111: 394-7.
26. Ram Shankar M, Girirajan S, Dagan O, Ravi Shankar HM, Jalvi R, Rangasayee R, et al. Contribution of connexin 26 (GJB2) mutations and founder effect to nonsyndromic hearing loss in India. J Med Genet 2003; 40: e68.
27. Maheshwari M, Vijaya R, Ghosh M, Shastri S, Kabra M, Menon PS. Screening of families with autosomal recessive non-syndromic hearing impairment (ARNSHI) for mutations in GJB2 gene: Indian scenario. Am J Med Genet A 2003; 120: 180-4.
28. Santos RL, Wajid M, Pham TL, Hussan J, Ali G, Ahmad W, et al. Low prevalence of connexin 26 (GJB2) variants in Pakistani families with autosomal recessive non-syndromic hearing impairment. Clin Genet 2005; 67: 61-8.
29. Snoeckx RL, Djelantik B, Van Lae L, Van de Heyning P, Van Camp G. GJB2 (connexin 26) mutations are not a major cause of hearing loss in the Indonesian population. Am J Med Genet A 2005; 135: 126-9.
30. Sobe T, Vreugde S, Shahin H, Berlin M, Davis N, Kanaan M, et al. The prevalence and expression of inherited connexin 26 mutations associated with non syndromic hearing loss in the Israeli population. Hum Genet 2000; 106: 50-7.
31. Mustapha M, Salem N, Delague V, Chouery E, Ghassibeh M, Rai M, et al. Autosomal recessive non-syndromic hearing loss in the Lebanese population: prevalence of the 30delG mutation and report of two novel mutations in the connexin 26 (GJB2) gene. J Med Genet 2001; 38: E36.
32. Shahin H, Walsh T, Sobe T, Lynch E, King MC, Avraham KB, et al. Genetics of congenital deafness in the Palestinian population: multiple connexin 26 alleles with shared origins in the Middle East. Hum Genet 2002; 110: 284-9.
33. Najmabadi H, Cucci RA, Sahebjam S, Kouchakian N, Farhadi M, Kahrizi K, et al. GJB2 mutations in Iranians with autosomal recessive non-syndromic sensorineural hearing loss. Hum Mutat 2002; 19: 572.
34. Uyguner O, Emiroglu M, Uzumceu A, Hafiz G, Ghanbari A, Baserer N, et al. Frequencies of gap-and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss. Clin Genet 2003; 64: 65-9.
35. Bayazit YA, Cable BB, Cataloluk O, Kara C, Chamberlin P, Smith RJ, et al. GJB2 gene mutations causing familial hereditary deafness in Turkey. Int J Pediatr Otorhinolaryngol 2003; 67: 1331-5.
36. Tekin M, Boǧoclu G, Arican ST, Orman MN, Tastan H, Elsobky E, et al. Evidence for single origins of 35delG and delE120 mutations in the GJB2 gene in Anatolia. Clin Genet 2005; 67: 31-7.
37. Kalay E, Caylan R, Kremer H, de Brouwer AP, Karaguzel A. GJB2 mutations in Turkish patients with ARNSHL: prevalence and two novel mutations. Hear Res 2005; 203: 88-93.
38. Denoyelle F, Weil D, Maw MA, Wilcox SA, Lench NJ, Allen-Powell DR, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997; 6: 2173-7.
39. Murgia A, Orzan E, Polli R, Martella M, Vinanzi C, Leonardi E, et al. Cx26 deafness: mutation analysis and clinical variability. J Med Genet 1999; 36: 829-32.
40. Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, Garabedian EN, et al. Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: implications for genetic counselling. Lancet 1999; 353: 1298-03.
41. Roux AF, Pallares-Ruiz N, Vielle A, Faugere V, Templin C, Leprevost D, et al. Molecular epidemiology of DFNB1 deafness in France. BMC Med Genet 2004; 5: 5-10.
42. Wiszniewski W, Sobieszezanska-Radoszewska L, Nowakowska-Szyrwinska E, Obersztyn E, Bal J. High frequency of GJB2 gene mutations in Polish patients with prelingual non-syndromic deafness. Genet Test 2001; 5: 147-8.
43. Pampanos A, Economides J, Iliadou V, Neou P, Leotsakos P, Voyiatzis N, et al. Prevalance of GJB2 mutations in prelingual deafness in the Greek population. Int J Pediatr Otorhinolaryngol 2002; 65: 101-8.
44. Iliades T, Eleftheriades N, Iliadou V, Pampanos A, Voyiatzis N, Economides J, et al. Prelingual non syndromic hearing loss in Greece. Molecular clinical findings. ORL J Otorhinolaryngol Relat Spec 2002; 64: 321-3.
45. Frei K, Szuhai K, Lucas T, Weipoltshammer K, Schöfer C, Ramsebner R, et al. Connexin 26 mutations in cases of sensorineural deafness in eastern Austria. Eur J Hum Genet 2002; 10: 427-32.
46. Janecke AR, Hirst-stadlmann A, Güther B, Utermann B, Müller T. Loffler J, et al. Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations-phenotypic spectrum and frequencies of GJB2 mutations in Austria. Hum Genet 2002; 111: 145-53.
47. Medlej-Hashim M, Mustapha M, Chouery E, Weil D, Parronaud J, Salem N, et al. Non-syndromic recessive deafness in Jordan: mapping of a new locus to chromosome 9q34.3 and prevalence of DFNB1 mutations. Eur J Hum Genet 2002; 10: 391-4.
48. Kupka S, Braun S, Aberle S, Haack B, Ebauer M, Zeissler U, et al. Frequencies of GJB2 mutations in German control individuals and patients showing sporadic non-syndromic hearing impairment. Hum Mutat 2002; 20: 77-8.
49. Zoll B, Petersen L, Lange K, Gabriel P, Kiese-Himmel C, Rausch P, et al. Evaluation of Cx26/GJB2 in German hearing impaired persons: mutation spectrum and detection of disequilibrium between M34T(c.101T>C) and-493del10. Hum Mutat 2003; 21: 98.
50. Minarik G, Ferak V, Ferakova E, Ficek A, Polakova H, Kadasi L. High frequency of GJB2 mutation W24X among Slovak Romany (Gypsy) patients with non-syndromic hearing loss (NSHL). Gen Physiol Biophys 2003; 22: 549-56.
51. Seeman P, Malikova M, Raskova D, Bendova O, Groh D, Kubalkova M, et al. Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness. Clin Genet 2004; 66: 152-7.
52. Toth T, Kupka S, Haack B, Riemann K, Braun S, Fazakas F, et al. GJB2 mutations in patients with non-syndromic hearing loss from Northeastern Hungary. Hum Mutat 2004; 23: 631-2.
53. Alvarez A, del Castillo I, Villamar M, Aguirre LA, Gonzalez-Neira, A, Lopez-Nevot A, et al. High prevalence of the W24X mutation in the gene encoding connexin-26 (GJB2) in Spanish Romani (Gypsies) with autosomal recessive non- syndromic hearing loss. Am J Med Genet A 2005; 137: 255-8.
54. Posukh O, Pallares-Ruiz N, Tadinova V, Osipova L, Claustres M, Roux AF. First molecular screening of deafness in the Altai Republic population. BMC Med Genet 2005; 6: 12.
55. Masmoudi S, Elgaied-Boulila A, Kassab I, Ben Arab S, Blanchard S, Bouzouita JE, et al. Determination of the frequency of connexin 26 mutations in inherited sensorineural deafness and carrier rates in the Tunisian population using DGGE. J Med Genet 2000; 37: E39.
56. Gasmelseed NM, Schmidt M, Magzoub MM, Macharia M, Elmustafa OM, Ototo B, et al. Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants. Hum Mutat 2004; 23: 206-7.
57. Dahl HH, Saunders K, Kelly TM, Osborn AH, Wilcox S, Cone-Wesson B, et al. Prevalence and nature of connexin 26 mutations in children with non-syndromic deafness. Med J Aust 2001; 175: 191-4.
58. Prasad S, Cucci RA, Green GE, Smith RJ. Genetic testing for hereditary hearing loss: Connexin 26 (GJB2) allele variants and two novel deafness-causing mutations (R32C and 645-648delTAGA). Hum Mutat 2000; 16: 502-8.
59. Pandya A, Arnos KS, Xia XJ, Welch KO, Blanton SH, Friedman TB, et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med 2003; 5: 295-303.
60. Kokotas H, Petersen MB, Willems PJ. Mitochondrial deafness. Clin Genet 2007; 71: 379-91.
61. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
62. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
63. Fernandez-Silva P, Enriquez JA, Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 2003;88:41-56.
64. Attardi G, Schatz G. Biogenesis of mitochondria. Annu Rev Cell Biol 1988; 4: 289-333.
65. Mitomap: A human mitochondrial genome database. Available from: http://www.mitomap.org, 2009.
66. Wallace DC, Lott MT, Brown MD, Huoponen K, Torroni A. Report of the committee on human mitochondrial DNA. In: Cuticchia AJ, editors. Human gene mapping: a compendium. Baltimore; John Hopkins University Press; 1995. p. 910-54.
67. Fischel-Ghodsian N, Bykhovskaya Y, Taylor K, Kahen T, Cantor R, Ehrenman K, et al. Temporal bone analysis of patients with presbycusis reveals high frequency of mitochondrial mutations. Hear Res 1997; 110: 147-54.
68. Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry 1999; 74: 1188-99.
69. Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am 1995; 79: 761-87.
70. Sande MA, Mandell GL. Antimicrobial agents. In: Gilman AG, Rall TW, Nies AS, editors. Goodman and Gilmans the pharmacological therapeutics, 8th ed. NewYork: Pergamon Press; 1990. p. 1098-116.
71. Chamber HF, Sande MA. The aminoglycosides. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman A, editors. The pharmacological basis of therapeutics, 9th ed. New York: Mc-Graw-Hill; 1996. p. 1103-21.
72. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics 2005; 6: 27-36.
73. Davies J, Davis BD. Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. The effect of drug concentration. J Biol Chem 1968; 243: 3312-6.
74. Noller HF. Ribosomal RNA and translation. Annu Rev Biochem 1991; 60: 191-227.
75. Guan MX, Yan Q, Li X, Bykhouskaya Y, Gallo-Teran J, Hajek P, et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am J Hum Genet 2006; 79: 291-302.
76. Bacino C, Prezant TR, Bu X, Fournier P, Fischel-Ghodsian N. Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside-induced deafness. Pharmacogenetics 1995; 5: 165-72.
77. Zhao L, Young WY, Li R, Wang Q, Qian Y, Guan MX. Clinical evaluation and sequence analysis of the complete mitochondrial genome of three Chinese patients with hearing impairment associated with the 12S rRNA T1095C mutation. Biochem Biophys Res Commun 2004; 325: 1503-8.
78. Guan MX. Mitochondrial DNA mutations associated with aminoglycoside ototoxicity. Audiol Med 2006; 4: 170-8.
79. Fischel-Ghodsian N. Mitochondrial deafness mutations reviewed. Hum Mutat 1999; 13: 261-70.
80. Zimmermann RA, Thomas CL, Wower J. Structure and function of rRNA in the decoding domain and at the peptidyltransferase center. In: Hill WE, Moore PB, Dahlberg A, Schlessinger D, Garrett RA, Warner JR, editors. The ribosome: structure, function and evolution. Washington DC: American Society for Microbiology; 1990. p. 331-47.
81. Hutchin T, Haworth I, Higashi K, Fischel-Ghodsian N, Stoneking M, Saha N, et al. A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res 1993; 21: 4174-9.
82. Braverman I, Jaber L, Levi H, Adelman C, Arnos KS, Fischel-Ghodsian N, et al. Audiovestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. Arch Otolaryngol Head Neck Surg 1996; 122: 1001-4.
83. Estivill X, Govea N, Barcelo E, Badenas C, Romero E, Moral L, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 1998; 62: 27-35.
84. Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol 1993; 14: 399-403.
85. Fischel-Ghodsian N, Prezant TR, Chaltraw WE, Wendt KA, Nelson RA, Arnos KS, et al. Mitochondrial gene mutations is a significant predisposing factor in aminoglycoside ototoxicity. Am J Otolaryngol 1997; 18: 173-8.
86. Pandya A, Xia X, Radnaabazar J, Batsuuri J, Dangaansuren B, Fischel-Ghodsian N, et al. Mutation in the mitochondrial 12S r-RNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet 1997; 34: 169-72.
87. Usami S, Abe S, Akita J, Namba A, Shinkawa H, Ishii M, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 2000; 37: 38-40.
88. Li Z, Li R, Chen J, Liao Z, Zhu Y, Qian Y, et al. Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Hum Genet 2005; 117: 9-15.
89. Malik SG, Pieter N, Sudoyo H, Kadir A, Marzuki S. Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island southeast Asia. J Hum Genet 2003; 48: 480-3.
90. Tekin M, Duman T, Bogoclu G, Incesulu A, Comak E, Fitoz S, et al. Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey. Eur J Pediatr 2003; 162: 154-8.
91. Li R, Greiwald JH Jr, Yang L, Choo DI, Wenstrup RJ, Guan MX. Molecular analysis of the mitochondrial 12S rRNA and tRNA Ser(UCN) genes in paediatric subjects with nonsyndromic hearing loss. J Med Genet 2004; 41: 615-20.
92. Kupka S, Toth T, Wrobel M, Zeissler U, Szyfter W, Szyfter K, et al Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian and Polish patients. Hum Mutat 2002; 19: 308-9.
93. Østergaard E, Montserrat-Sentis B, Grønskov K, Brøndum-Nielsen K. The A1555G mtDNA mutation in Danish hearing-impaired patients: frequency and clinical signs. Clin Genet 2002; 62: 303-5.
94. Tang X, Yang L, Zhu Y, Liao Z, Wang J, Qian Y, et al. Very low penetrance of hearing loss in seven Han Chinese pedigrees carrying the deafness-associated 12S rRNA A1555G mutation. Gene 2007; 393: 11-9.
95. Guan MX. Molecular pathogenetic mechanism of maternally inherited deafness. Ann N Y Acad Sci 2004; 1011: 259-71.
96. Bykhovskaya Y, Estivill X, Taylor K, Hang T, Hamon M, Casano RA, et al. Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am J Hum Genet 2000; 66: 1905-10.
97. Abe S, Kelley PM, Kimberling WJ, Usami SI. Connexin 26 gene (GJB2) mutation modulates the severity of hearing loss associated with the 1555A→G mitochondrial mutation. Am J Med Genet 2001; 103: 334-8.
98. Bronya JB, Keats Charles IB, Gregory P. Epidemiology of genetic hearing loss. Semin Hear 2006; 27: 136-47.
99. Young WY, Zhao L, Qian Y, Wang Q, Li N, Greinwald JH Jr, et al. Extremely low penetrance of hearing loss in four Chinese families with the mitochondrial 12S rRNA A1555G mutation. Biochem Biophys Res Commun 2005; 328: 1244-51.
100. Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, et al. A novel mitochondrial 12S rRNA point mutation in Parkinsonism, deafness and neuropathy. Ann Neurol 2002; 48: 730-6.
101. Tessa A, Giannotti A, Tieri L, Vilarinho L, Marotta G, Santorelli FM. Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur J Hum Genet 2001; 9: 147-9.
102. Guan MX, Fischel-Ghodsian N, Attardi G. A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 2000; 9: 1787-93.
103. Tang HY, Hutcheson E, Neill S, Drummond-Borg M, Speer M, Alford RL. Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk? Genet Med 2002; 4: 336-45.
104. Yoshida M, Shintani T, Hirao M, Himi T, Yamaguchi A, Kikuchi K. Aminoglycoside- induced hearing loss in a patient with the 961 mutation in mitochondrial DNA. ORL J Otorhinolaryngol Relat Spec 2002; 64: 219-22.